Portopulmonary hypertension (POPH) and hepatopulmonary syndrome (HPS) are two
frequent complications of liver disease, with prevalence among liver transplant candidates of …

Hepatopulmonary syndrome (HPS) is a pulmonary complication observed in patients with
chronic liver disease and/or portal hypertension, attributable to an intrapulmonary vascular …

Background/Aim TNF‐α is increased in hepatopulmonary syndrome (HPS). Pentoxifylline
(PTX) mitigated experimental HPS through the inhibition of TNF‐α. However, PTX has …

Abstract Background & Aims Hepatopulmonary syndrome in children has not been
extensively studied particularly in different subsets of portal hypertension. We prospectively …

Hepatopulmonary syndrome (HPS) is a rare complication of liver diseases of different
etiologies and may indicate a poor prognosis. Therefore, a simple non-invasive screening …

Background: Pulmonary dysfunction including the hepatopulmonary syndrome (HPS) is an
important complication to cirrhosis and portal hypertension. However, the precise relation to …

Background and aims One central factor in hepatopulmonary syndrome (HPS) pathogenesis
is intravascular accumulation of activated macrophages in small pulmonary arteries …

Hepatopulmonary syndrome (HPS)—a pulmonary complication observed in patients who
have chronic liver disease and/or portal hypertension—is attributed to intrapulmonary …

Although liver transplantation (LT) is the only effective treatment option for hepatopulmonary
syndrome (HPS), the post-LT morbidity and mortality have been high for patients with severe …

Hypertrophic osteoarthropathy is an uncommon disease in the pediatric age group
characterized by noninflammatory joint effusions, terminal digit clubbing, and radiographic …